RFA
CRDF icon

Reilly Financial Advisors’s Cardiff Oncology CRDF Stock Holding History

Reilly Financial Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-35
Closed -$11K – 846
2016
Q3 		$11K Hold
35
– – ﹤0.01% 509
2016
Q2 		$11K Buy
35
+3
+9% +$1.03K ﹤0.01% 482
2016
Q1 		$11K Buy
32
+5
+19% +$1.7K ﹤0.01% 736
2015
Q4 		$10K Hold
27
– – ﹤0.01% 778
2015
Q3 		$11K Hold
27
– – ﹤0.01% 752
2015
Q2 		$20K Buy
+27
New +$19.2K ﹤0.01% 677

Other funds holding CRDF

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Reilly Financial Advisors's CRDF Position: Q4 2016 in Review

Reilly Financial Advisors sold out of Cardiff Oncology (CRDF) in Q4 2016, closing a stake of 35 shares — an estimated $11K sold.

Reilly Financial Advisors first reported a position in CRDF in Q2 2015 and held it in 6 quarters. The position peaked at $20K in Q2 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

  • Reilly Financial Advisors reported no remaining Cardiff Oncology position as of Q4 2016 after selling out during the quarter.
  • Reilly Financial Advisors sold 35 Cardiff Oncology shares in Q4 2016, an estimated $11K.
  • Reilly Financial Advisors first reported a position in Cardiff Oncology in Q2 2015 and held it in 6 quarters.
  • Reilly Financial Advisors's Cardiff Oncology position peaked at $20K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on Reilly Financial Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.